A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients (pts) with advanced HER2+ breast cancer (BC) Meeting Abstract


Authors: Holden, S. N.; Beeram, M.; Krop, I. E.; Burris, H. A.; Birkner, M.; Girish, S.; Tibbitts, J.; Lutzker, S. G.; Modi, S.
Abstract Title: A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients (pts) with advanced HER2+ breast cancer (BC)
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 48s
Language: English
ACCESSION: WOS:000208457400245
PROVIDER: wos
DOI: 10.1200/jco.2008.26.15_suppl.1029
Notes: Meeting Abstract: 1029 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    265 Modi